
Press release
Karolinska Institutet and Cellply announce collaboration to advance NK cell-based therapy translational research with the VivaCyte platform
9 May 2025
In this webinar Silvia Bocchi, Assay Development Leader at Cellply, will show how our new Workflow 2 on VivaCyte, officially launched at SITC 2024 in Houston, can provide the scientific community with a powerful new potency assessment tool that enables more robust analysis with fewer resources.
Duration: 30 mins
Workflow 2 analyses 8 different conditions (e.g. edits, processes options) per CC-Array plate and up to 40 different samples per run.
KEY POINTS:
Robust results faster – 3x less hands-on time, 15x fewer pipetting steps and 3x less sample.
If you are in PD, this can revolutionize the way you work.